[go: up one dir, main page]

MX2023013577A - Composiciones de bismuto-tiol y metodos de uso. - Google Patents

Composiciones de bismuto-tiol y metodos de uso.

Info

Publication number
MX2023013577A
MX2023013577A MX2023013577A MX2023013577A MX2023013577A MX 2023013577 A MX2023013577 A MX 2023013577A MX 2023013577 A MX2023013577 A MX 2023013577A MX 2023013577 A MX2023013577 A MX 2023013577A MX 2023013577 A MX2023013577 A MX 2023013577A
Authority
MX
Mexico
Prior art keywords
bismuth
methods
thiol
thiol compositions
subject
Prior art date
Application number
MX2023013577A
Other languages
English (en)
Inventor
Brett Hugh James Baker
Jeffrey W Millard
Original Assignee
Microbion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbion Corp filed Critical Microbion Corp
Publication of MX2023013577A publication Critical patent/MX2023013577A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a compuestos de bis-tiol y preparaciones farmacéuticas de estos; la invención se refiere, además, a métodos para tratar, controlar o disminuir la gravedad de las infecciones pulmonares en un sujeto, el método comprende administrar al sujeto una composición de bismuto-tiol (BT) que comprende al menos un compuesto de BT.
MX2023013577A 2018-07-31 2021-01-29 Composiciones de bismuto-tiol y metodos de uso. MX2023013577A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862712563P 2018-07-31 2018-07-31
US201962800925P 2019-02-04 2019-02-04

Publications (1)

Publication Number Publication Date
MX2023013577A true MX2023013577A (es) 2023-11-30

Family

ID=69231251

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2021001272A MX2021001272A (es) 2018-07-31 2019-07-31 Composiciones de bismuto-tiol y metodos de uso.
MX2023013577A MX2023013577A (es) 2018-07-31 2021-01-29 Composiciones de bismuto-tiol y metodos de uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2021001272A MX2021001272A (es) 2018-07-31 2019-07-31 Composiciones de bismuto-tiol y metodos de uso.

Country Status (13)

Country Link
US (2) US11464749B2 (es)
EP (1) EP3829307A4 (es)
JP (1) JP7564101B2 (es)
KR (1) KR20210084425A (es)
CN (1) CN112804878A (es)
AU (1) AU2019315509B2 (es)
BR (1) BR112021001731A2 (es)
CA (1) CA3107760A1 (es)
IL (1) IL280414B2 (es)
MX (2) MX2021001272A (es)
SG (1) SG11202100823RA (es)
WO (1) WO2020028558A1 (es)
ZA (1) ZA202100780B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3829299A4 (en) 2018-07-31 2022-04-13 Microbion Corporation BISMUTH THIOL COMPOSITIONS AND METHODS OF TREATMENT OF WOUNDS
JP7564101B2 (ja) 2018-07-31 2024-10-08 マイクロビオン コーポレーション ビスマスチオール組成物及び使用方法
US20230124862A1 (en) * 2020-03-24 2023-04-20 Jeffrey W. MILLARD Bismuth thiol compounds and compositions and methods of treating microbial co-infections
US20250002514A1 (en) * 2021-01-25 2025-01-02 Microbion Corporation Amorphous form of bismuth-1,2-ethanedithiol and methods of making
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
WO2023063827A1 (en) * 2021-10-15 2023-04-20 Omnicin Therapeutics B.V. Synergistic composition against pseudomonas aeruginosa
CA3248355A1 (en) * 2022-01-10 2023-07-13 Microbion Corp METHODS OF TREATMENT FOR NON-TUBERCULOUS MYCOBACTERIAL DISEASES

Family Cites Families (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
USRE29409E (en) 1965-03-15 1977-09-20 Ventron Corporation Phenoxarsine compounds incorporated into resins with phenols
US3452034A (en) 1967-03-09 1969-06-24 American Cyanamid Co Substituted 2-(1,3,4-thiadiazol-2-yl)-4(5)-nitroimidazoles
IE51759B1 (en) 1980-08-15 1987-03-18 Scott Bader Co Coating compositions
US4596724A (en) 1984-05-15 1986-06-24 Marine Shield Corp. Anti-fouling coating composition, process for applying same and coating thereby obtained
US4788302A (en) 1985-06-14 1988-11-29 Duke University Anti-fouling compound and method of use
JPH0653735B2 (ja) 1987-08-03 1994-07-20 明治製菓株式会社 Ｎ−アルキルベンゼンスルホニルカルバモイル−５−クロロイソチアゾ−ル誘導体および殺微生物剤
DE69020758T2 (de) 1989-03-10 1995-12-07 Yamanouchi Pharma Co Ltd Die Wirkstoffabgabe steuerndes Überzugsmaterial für lang wirksame Formulierungen.
US5229124A (en) 1990-04-02 1993-07-20 Morton International, Inc. Microbicides immobilized in water soluble thermoplastic resins and aqueous dispersions of microbicides prepared therefrom
US5194248A (en) 1990-06-21 1993-03-16 Trustees Of Boston University Compositions comprising vitamin D analog precursors and the use thereof
JPH04325569A (ja) 1991-04-24 1992-11-13 Ishihara Sangyo Kaisha Ltd 防汚塗料組成物
US6488912B1 (en) 1992-07-30 2002-12-03 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of dentoalveolar infections with taurolidine and/or taurultam
US5334389A (en) 1992-10-15 1994-08-02 Duke University Antifouling coating and method for using same
US5384176A (en) 1992-12-11 1995-01-24 Zimmerman; Richard C. Phenolic acid sulfate esters for prevention of marine biofouling
US5928671A (en) 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US6558686B1 (en) 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
US6071528A (en) 1997-02-19 2000-06-06 Ultradent Products, Inc. Adhesive antimicrobial and/or reparative dentin stimulating dental compositions and methods for forming and using such compositions
US6017936A (en) 1997-03-14 2000-01-25 Arch Chemicals, Inc. Method for producing particles of pyrithione salts and particles so produced
US5999828A (en) 1997-03-19 1999-12-07 Qualcomm Incorporated Multi-user wireless telephone having dual echo cancellers
US6455031B1 (en) 1997-06-18 2002-09-24 David G Davies Methods and compositions for controlling biofilm development
AU2003204105B2 (en) 1997-10-28 2005-11-17 Winthrop-University Hospital Metal/Thiol Biocides
JPH11158328A (ja) 1997-11-27 1999-06-15 Fujikura Rubber Ltd 抗菌性ゴム部品
AU2656799A (en) 1998-02-04 1999-08-23 Winthrop-University Hospital Metal-thiols as imminomodulating agents
GB9802355D0 (en) 1998-02-04 1998-04-01 Ciba Geigy Ag Organic compounds
US6465015B1 (en) 1998-02-24 2002-10-15 Arch Chemicals, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
TWI245763B (en) 1998-04-02 2005-12-21 Janssen Pharmaceutica Nv Biocidal benzylbiphenyl derivatives
EP1115394A2 (en) 1998-09-23 2001-07-18 Phycogen, Inc. Pharmaceutical compositions comprising derivatives of sulphur acids
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6261539B1 (en) 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6682724B2 (en) 1999-02-23 2004-01-27 Arch Chemcials, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
JP2000336080A (ja) 1999-05-28 2000-12-05 Nippon Bayer Agrochem Co Ltd イソチアゾールカルボキサミド類
WO2001064644A1 (en) 2000-03-01 2001-09-07 Nihon Bayer Agrochem K.K. Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU1029901A (en) 2000-10-16 2002-04-29 Biocosmetics Sl Use of olive oil in the preparation of a product for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in the mouth
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6630172B2 (en) 2001-01-22 2003-10-07 Kareem I. Batarseh Microbicidal composition containing potassium sodium tartrate
US6582719B2 (en) 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
US7547433B2 (en) 2001-02-15 2009-06-16 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6448306B1 (en) 2001-03-23 2002-09-10 Milliken & Company Antimicrobial articles made from nitrile or natural rubber
AU2002306639A1 (en) 2001-03-23 2002-10-08 Milliken And Company Antimicrobial rubber compositions
US6555599B2 (en) 2001-03-26 2003-04-29 Milliken & Company Antimicrobial vulcanized EPDM rubber articles
US6730324B2 (en) 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
AU2002312416A1 (en) 2001-06-07 2003-12-22 Chiou Consulting, Inc Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
US6638993B2 (en) 2001-12-12 2003-10-28 Milliken & Company Colored antimicrobial vulcanized rubber articles
US6579513B1 (en) 2002-01-03 2003-06-17 Playtex Products, Inc. Hygiene mouthspray composition
US7438925B2 (en) 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
JP4357166B2 (ja) 2002-10-21 2009-11-04 日揮触媒化成株式会社 抗菌・防黴・防藻性組成物
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US6861049B2 (en) 2002-11-12 2005-03-01 Douglas B. Harwood Aqueous slurries useful for cleaning the tongue and throat
US6848871B1 (en) 2002-12-19 2005-02-01 Cottrell, Inc. Strap tie-down system
WO2008043175A1 (en) 2006-10-13 2008-04-17 Kane Biotech Inc. SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF
JP2004307483A (ja) 2003-04-07 2004-11-04 Rohm & Haas Co 殺微生物組成物
US6852782B2 (en) 2003-04-25 2005-02-08 Milliken & Company Antimicrobial articles and compositions made from non-silicone vulcanized rubber
US7060739B2 (en) 2003-04-25 2006-06-13 Milliken & Company Antimicrobial fluoroelastomer rubber articles and compositions
US6943205B2 (en) 2003-04-25 2005-09-13 Milliken & Company Antimicrobial articles and compositions made from styrene butadiene rubber
US6875453B2 (en) 2003-07-18 2005-04-05 Manuel Viamonte, Jr. Non-toxic disinfectant containing a isopropyl alcohol and sesame oil composition with lemon oil and menthol
US7381751B2 (en) 2003-08-26 2008-06-03 Shantha Sarangapani Antimicrobial composition for medical articles
EP1809243B2 (de) 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
AU2005298344B2 (en) 2004-10-25 2011-02-10 Varian Medical Systems, Inc. Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US7419681B2 (en) 2004-12-02 2008-09-02 Bioretec, Ltd. Method to enhance drug release from a drug-releasing material
US20090191254A1 (en) 2004-12-06 2009-07-30 The Govt. Of The U.S.A., Centers For Disease Control And Prevention Inhibition of biofilm formation using bacteriophage
US20060205838A1 (en) 2005-03-10 2006-09-14 Velamakanni Bhaskar V Hardenable antimicrobial dental compositions and methods
WO2006125319A1 (en) 2005-05-26 2006-11-30 Gangagen Life Sciences Inc. Bacterial management in animal holding systems
US7507281B2 (en) 2005-09-02 2009-03-24 Microban Products Company Antimicrobial cementitious composition, method and article
CA2626016A1 (en) 2005-10-21 2007-06-21 Panacea Biotec Limited Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
US8268395B2 (en) 2005-12-05 2012-09-18 E. I. Du Pont De Nemours And Company Method for providing resistance to biofouling in a porous support
JP4568232B2 (ja) 2006-01-06 2010-10-27 秀和 西松 人工骨頭保持具
JP2007332040A (ja) 2006-06-12 2007-12-27 Shinshu Univ カーボンナノチューブを含む抗菌剤とそれを用いた材料及び製剤
GB0618697D0 (en) 2006-09-22 2006-11-01 Syntopix Ltd Formulations
US10525433B2 (en) 2006-12-12 2020-01-07 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
AU2008207864B2 (en) 2007-01-24 2013-07-11 Cook Biotech Incorporated Biofilm-inhibiting medical products
US8343536B2 (en) 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
CA2687628A1 (en) 2007-05-18 2008-11-27 Agion Technologies, Inc. Bioactive agrichemical compositions and use thereof
JP5642540B2 (ja) 2007-06-01 2014-12-17 アロウ・インターナショナル・インコーポレイテッドＡｒｒｏｗ Ｉｎｔｅｒｎａｔｉｏｎａｌ， Ｉｎｃ． 組み合わされた線維素溶解性および抗菌性のカテーテル、およびその使用
BRPI0721916A2 (pt) 2007-07-25 2015-05-05 Celonova Biosciences Inc Partículas poliméricas codificadas por cor e dimensionadas para aplicações terapêuticas e/ou diagnósticas e métodos de preparação e uso das mesmas
EP2237788A4 (en) 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
US20090197003A1 (en) 2008-02-01 2009-08-06 Thomas Van Zandt Anti-fouling coatings, Compounds, and methods
US7939096B2 (en) 2008-02-12 2011-05-10 Boston Scientific Scimed, Inc. Medical implants with polysaccharide drug eluting coatings
WO2009154819A2 (en) 2008-03-10 2009-12-23 The Charlotte-Mecklenburg Hospital Authority Treatment of inflammatory conditions and diseases with metal-thiols
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US9028878B2 (en) * 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
AU2010210620B2 (en) 2009-02-03 2016-02-25 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US20200138033A1 (en) * 2009-02-03 2020-05-07 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
KR102074444B1 (ko) 2010-02-03 2020-02-06 마이크로비온 코포레이션 세균 균막의 치료 및 다른 용도를 포함하는, 생의학적 용도를 위한 방부제로서 비스무트-티올
JP2013518895A (ja) * 2010-02-03 2013-05-23 マイクロビオン コーポレーション 細菌バイオフィルムの処置および他の使用をはじめとする、生体医学的使用のための消毒薬としてのビスマス−チオール
JP6336246B2 (ja) 2013-03-13 2018-06-06 大同化成工業株式会社 ナノ粒子化製剤及びその製造方法
CN105246598B (zh) 2013-03-15 2019-09-13 太阳药业环球公司 乙酸阿比特龙酯制剂
JP6567648B2 (ja) 2014-07-28 2019-08-28 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドＳｕｎ Ｐｈａｒｍａ Ａｄｖａｎｃｅｄ Ｒｅｓｅａｒｃｈ Ｃｏｍｐａｎｙ Ｌｉｍｉｔｅｄ 薬物のバイオアベイラビリティーの増加および／または眼作用の持続方法
PL3328361T3 (pl) 2015-07-27 2021-12-13 Sun Pharma Advanced Research Company Ltd Cząstki nanożywicy zawierające lek
JP7564101B2 (ja) 2018-07-31 2024-10-08 マイクロビオン コーポレーション ビスマスチオール組成物及び使用方法
EP3829299A4 (en) 2018-07-31 2022-04-13 Microbion Corporation BISMUTH THIOL COMPOSITIONS AND METHODS OF TREATMENT OF WOUNDS

Also Published As

Publication number Publication date
MX2021001272A (es) 2021-07-15
BR112021001731A2 (pt) 2021-04-27
IL280414A (en) 2021-03-25
KR20210084425A (ko) 2021-07-07
WO2020028558A1 (en) 2020-02-06
JP2021533193A (ja) 2021-12-02
IL280414B1 (en) 2024-10-01
US11464749B2 (en) 2022-10-11
JP7564101B2 (ja) 2024-10-08
AU2019315509A1 (en) 2021-02-18
CA3107760A1 (en) 2020-02-06
EP3829307A1 (en) 2021-06-09
EP3829307A4 (en) 2022-08-03
US20230165808A1 (en) 2023-06-01
CN112804878A (zh) 2021-05-14
AU2019315509B2 (en) 2025-06-26
US20200046650A1 (en) 2020-02-13
ZA202100780B (en) 2023-07-26
IL280414B2 (en) 2025-02-01
SG11202100823RA (en) 2021-02-25
US12186283B2 (en) 2025-01-07

Similar Documents

Publication Publication Date Title
MX2023013577A (es) Composiciones de bismuto-tiol y metodos de uso.
MY198425A (en) Glp-1 Compositions and uses Thereof
MX2020009956A (es) Compuestos para el tratamiento de enfermedad de hungtinton.
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
MX2021001091A (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington.
PH12020500257A1 (en) Quinoline derivatives for treating infections with helminths
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MA40241A (fr) Compositions enrichies stéréochimiquement pour l'administration d'acides nucléiques
WO2019120234A3 (zh) 作为溴结构域蛋白质抑制剂的化合物和组合物
MX2021003773A (es) Composiciones farmacéuticas y métodos relacionados con los agentes terapéuticos óticos.
PH12021550705A1 (en) Stable semaglutide compositions and uses thereof
BR112017000246A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, e, uso de um composto ou de um sal
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
MX2019000428A (es) Agentes y metodos para la prevencion o el tratamiento de infecciones por h. pylori.
NO20180002A1 (en) Aminobenzisoxazole compounds as agonists of A7-nicotinic acetylcholine receptors
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
NZ757526A (en) Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction
EA201890075A1 (ru) Инъецируемые фармацевтические композиции лефамулина
PH12020551618A1 (en) Erenumab compositions and uses thereof
PH12020500204A1 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic disease
MX2020009496A (es) Metodo para tratar asma o enfermedad alergica.
ZA202001568B (en) Methods and compositions for treating chronic lung diseases
MX2020012609A (es) Inhibidor del hif-1?, metodo de preparacion del mismo, y composicion farmaceutica para prevenir o tratar la enfermedad ocular asociada a la angiogenesis, que contiene el mismo como ingrediente activo.
PH12020550549A1 (en) Compositions for preventing or treating lupus